6-Min Walk Test in Patients w/Transthyretin Cardiac Amyloidosis | ESC Heart Failure 2024
Harlan Krumholz, MD, FACC, incoming Editor-in-Chief of JACC interviews Marianna Fontana, MD, PhD, about the prognostic value of a 6-minute walk test in patients with transthyretin cardiac amyloidosis. This paper was simultaneously published in JACC to coincide with research presented during ESC Heart Failure 2024.
▶︎
The Future for Patients with ATTR Cardiac Amyloidosis is Brighter
▶︎
Cardiac Amyloidosis: The Heart of the Matter
▶︎
Cardiac Cachexia, Heart Failure, and Nutrition
▶︎
Six Minute Walk Test
▶︎
Amyloidosis - Dr Lachmann (London, UK)
▶︎
Mythbusters: Cardiac Amyloidosis with Amrut Ambardekar, MD
▶︎
Insights from STEP-HFpEF Trial | ESC Heart Failure 2024
▶︎
Expert Perspectives on the 2026 Acute PE Guideline | JACC Journal Club
▶︎
Cardiac Amyloidosis: Update on Diagnosis and Treatment
▶︎
Amyloidosis and the Heart
▶︎
Fixing the misfolded proteins that cause dementia and heart failure
▶︎
How Does the Six Minute Walk Test Work?
▶︎
Cardiac Amyloidosis Treatment and Care with Dr. Jan Griffin
▶︎
What’s new in AA Amyloidosis in 2020 ?
▶︎
Doctor Explains The Best Foods To Eat to Lower Blood Sugar FAST
▶︎
Understanding Cardiac Amyloidosis: Evaluation and Diagnosis w/ Mathew S. Maurer, MD
▶︎
17) Amyloid Afternoon Pane - Updates in Amyloidosis (2.3.2024)
▶︎
Cardiac Amyloidosis: An Underdiagnosed, Not Rare Disease | DoM Grand Rounds | 15 Feb 2023
▶︎
Imaging in ATTR Cardiac Amyloidosis: How it is used for Diagnosis and Treatment Response
▶︎